Changhoon Yoo

机构：Ulsan College, Asan Medical Center, University of Ulsan · ORCID：0000-0002-1451-8455

发表论文 455 篇 · 总被引 8529 次 · h-index 47

代表论文

• Multicenter single-arm phase II trial of lenvatinib in patients with advanced hepatocellular carcinoma after progression on first-line atezolizumab plus bevacizumab (2025 · Journal of Hepatology · 被引 19)
• Durvalumab in Advanced Biliary Tract Cancer: Real‐World Data From a Large Cohort of Patients Across Multiple International Centers (2025 · Liver International · 被引 10)
• A Prognostic Index for Advanced Biliary Tract Cancer Treated With Cisplatin, Gemcitabine and Durvalumab: The MAGIC ‐D Index (2025 · Liver International · 被引 9)
• Negative impact of corticosteroid use on outcome in patients with advanced BTCs treated with cisplatin, gemcitabine, and durvalumab: A large real‐life worldwide population (2025 · International Journal of Cancer · 被引 4)
• The impact of molecular alterations in patients with advanced biliary tract cancer receiving cisplatin, gemcitabine, and durvalumab: a large, real-life, worldwide population (2025 · JNCI Journal of the National Cancer Institute · 被引 4)
• Association of candidate surrogate endpoints with overall survival in advanced biliary tract cancer (2025 · Journal of Hepatology · 被引 4)